Snapshot · The Diary Of A CEO with Steven Bartlett
Objects in low Earth orbit travel at roughly 17,000 miles per hour — making even a fleck of paint carry the destructive force of a rifle bullet or exploding grenade.
Where this was said
At 1:00:30 · chapter starts 59:58
The conversation shifts to the growing congestion in low Earth orbit. Steven Bartlett notes that roughly 5,000 new satellite objects were launched in 2025 alone, and Tyson confirms SpaceX's Starlink constellation reached 10,510 as of the mid-2026 recording. The economic justification is real — GPS underpins Uber's entire business model, and Starlink brings high-speed internet to remote regions — but the risks are mounting. [1] — Neil deGrasse Tyson "If enough satellites crowd low Earth orbit and one is destroyed, the resulting debris traveling at 17,000 mph will strike other satellites,…" 58:00 Tyson explains Kessler Syndrome, first described in 1978: past a critical density threshold, a single satellite collision creates debris traveling at 17,000 mph — far faster than a rifle bullet — which strikes other satellites, each breaking into ten pieces, cascading until 100% of satellites could be destroyed. Four nations (China, India, Russia, and the US) have already demonstrated anti-satellite weapons. The movie Gravity, Tyson notes, portrays exactly this scenario. The future of astronomy, he concludes, lies in space-based or lunar telescopes precisely to escape this problem.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.